Johnson Pharmacare Ltd — Important, 01-06-2026: Company Update

Johnson Pharmacare's board has approved the audited financial results for the quarter and financial year ended March 31, 2026. Auditors issued a qualified opinion, highlighting non-provision of loan interest, non-compliance with accounting standards, and significant cash losses of 1,112.35 Cr this year (5.84 Cr last year). They stressed the company cannot meet its liabilities within one year, exceeded investment limits, and faces valuation issues for unquoted investments. The auditors also noted the company should be registered under the RBI Act. Two directors, Rajendra Prasad and Umesh Kumar, resigned due to personal reasons.